Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E-Mart | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩2.3T | -4.3x | 0.01 | ₩90,600 | 4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.7% Upside | Upgrade to Pro+ | |
BGF Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩1.93T | 9.5x | -2.87 | ₩123,900 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.6% Upside | Upgrade to Pro+ | |
Gs Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩1.3T | -25x | 0.15 | ₩17,650 | 13.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.3% Upside | Upgrade to Pro+ | |
Hyundai Green Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩600.36B | 8.1x | 0.35 | ₩18,160 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
SPC Samlip | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩444.17B | 5.1x | 0.07 | ₩55,400 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curexo | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩410.08B | -15.6x | ₩9,810 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CJ Freshway | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩338.93B | 14.7x | -0.21 | ₩28,400 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.4% Upside | Upgrade to Pro+ | |
Kyochon | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩257.32B | 463.7x | -5.1 | ₩5,380 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinsegae Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩140.76B | 11.4x | -0.85 | ₩36,550 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.9% Upside | Upgrade to Pro+ | |
Boratr | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩67.65B | 10.2x | -0.32 | ₩10,290 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seouleaguer | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩61.89B | 14x | 0.18 | ₩721 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KBio Company | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩32.22B | -4.3x | -0.11 | ₩278 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CuroHoldings | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩19.61B | -0.8x | 0.01 | ₩898 | 6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |